As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as capsule / tablet. HHC capsule -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as beverage. HHC drink -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as edible / ingestible. HHC edible -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as flower / raw plant. HHC flower -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as other. HHC other -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as powder / bulk. HHC powder -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as raw material / ruo. HHC raw material -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as tincture / sublingual. HHC tincture -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as topical. HHC topical -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
As of October 22, 2026, HHC (Hexahydrocannabinol) is illegal to sell (federally scheduled; state law on file reads illegal) in Ohio as vape / inhalable. HHC vape -- federally Schedule I (DEA drug code 7220). Controlling source: Ohio Revised Code Section 928.01 (Definitions), as amended by 2025-2026 Senate Bill 56, effective 3/20/2026.
Verified October 22, 2026 (hash check) · confidence: confirmed"Hemp" does not include ... Any final hemp-derived cannabinoid product containing ... (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant.
| Form | Status | Headline | Verified |
|---|---|---|---|
| Capsule / tablet | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Beverage | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Edible / ingestible | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Flower / raw plant | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Other | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Powder / bulk | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Raw material / RUO | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Tincture / sublingual | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Topical | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
| Vape / inhalable | Illegal | Federally scheduled (schedule_i eff. 2026-05-04) · state law: illegal | 2026-10-22 |
Among Ohio's 5 neighbors, Indiana, Kentucky, Michigan, Pennsylvania and West Virginia are illegal, the same posture as Ohio.
Map and neighbor comparison show capsule / tablet. Open the interactive map · Every compound in Ohio
Federally scheduled or prohibited. HHC capsule -- federally Schedule I (DEA drug code 7220) Federal detail
4 instruments on file for this compound's framework in Ohio; 60 of 60 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
6c140edf84af933dAs used in this chapter: (A) "Container" means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge. "Container" does not include bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use. (C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (E) "Hemp-derived cannabinoid product" means any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" does not include a drug that is the subject of an application approved under subsection (c) or (j) of 21 U.S.C. 355. (H) "Intermediate hemp-derived cannabinoid product" means a hemp-derived cannabinoid product that is either of the following: (1) Not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; (2) A powder, liquid, tablet, oil, or other product form that is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
eda464f28d51571e(C) "Hemp" means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of not more than three-tenths per cent on a dry weight basis. "Hemp" includes industrial hemp. "Hemp" does not include any of the following: (1) Any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration, including tetrahydrocannabinolic acid, of three-tenths per cent in the plant on a dry weight basis; (2) Any intermediate hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) More than three-tenths per cent combined total of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed to have similar effects on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code. (3) Any intermediate hemp-derived cannabinoid product that is marketed or sold as a final product or directly to an end consumer for personal or household use; (4) Any final hemp-derived cannabinoid product containing any of the following: (a) Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; (b) Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant and were synthesized or manufactured outside the plant; (c) Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects, or are marketed to have similar effects, on humans or animals as a tetrahydrocannabinol as established by the superintendent of cannabis control in lists adopted under section 928.031 of the Revised Code.
5ca11dce0915c0e2928.01 (C) "'Hemp' means the plant Cannabis sativa L. and any part of that plant" [...] [with a total THC concentration] "of not more than three-tenths per cent on a dry weight basis" [where total THC means] "total tetrahydrocannabinols, including tetrahydrocannabinolic acid". (C)(4) [Hemp does not include final hemp-derived cannabinoid products containing:] (a) "Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant" [...] (c) "Greater than four-tenths of a milligram combined total per container of total tetrahydrocannabinols" [...]. (E) ["Hemp-derived cannabinoid product" means] "any intermediate or final product derived from hemp, other than industrial hemp" [intended for human or animal use by means] "such as inhalation, ingestion, or topical application". [Bracketed spans summarized; authenticated PDF dated 3-20-2026.]
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap